Drug intelligence / Profile preview

B-9 plus capsules

Development stage
Unknown
Lead developer
Juggat Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

B-9 plus capsules is an approved oral nutraceutical and small molecule combination product developed by Juggat Pharma, a division of Jagdale Industries. Each capsule contains three active ingredients: elemental iron (50 mg, in the form of carbonyl iron), folic acid (0.5 mg), and zinc sulfate monohydrate (61.8 mg, equivalent to 22.5 mg of elemental zinc). It is indicated for the treatment and prevention of iron deficiency anemia, nutritional deficiencies, and dietary insufficiency, as well as for nutritional support during pregnancy and lactation to promote fetal growth and development. Carbonyl iron provides a highly pure, easily absorbed form of iron with low gastrointestinal irritation to support hemoglobin production. Folic acid (Vitamin B9) is essential for DNA synthesis and red blood cell maturation, while zinc is a critical cofactor for cellular growth and immune function. The product is marketed as an over-the-counter dietary supplement in India.

Brand names
B 9 PlusB9 PlusB-9 PlusB 9 Plus CapsuleB9 Plus CapsuleB-9 Plus CapsuleB-9 Plus CapsulesB9 Plus CapsulesB 9 Plus Capsules
Other names
carbonyl iron + folic acid + zinc sulfatecarbonyl iron + folic acid + zinc sulfate monohydrate
02

Targets

DHFR (Dihydrofolate reductase)FOLR1 (FRα)TFRC (Transferrin Receptor)

Beyond the preview

Go deeper on B-9 plus capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-9 plus capsules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call